Cargando…

Genotypic and Phenotypic Characteristics of Hereditary Leiomyomatosis and Renal Cell Cancer Syndrome in Korean Patients

BACKGROUND: Hereditary leiomyomatosis and renal cell cancer (HLRCC) is an autosomal dominant cancer predisposition syndrome. HLRCC is characterized by the development of cutaneous leiomyomas, early-onset uterine leiomyomas, and HLRCC-associated renal cell cancer (RCC) and caused by germline fumarate...

Descripción completa

Detalles Bibliográficos
Autores principales:	Seo, Ja Young, Ahn, Jeong-Yeal, Keam, Bhumsuk, Kim, Miso, Yoon, Shinkyo, Lee, Jae Lyun, Park, Kwonoh, Park, Inkeun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Korean Society for Laboratory Medicine 2021
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7591281/ https://www.ncbi.nlm.nih.gov/pubmed/33063682 http://dx.doi.org/10.3343/alm.2021.41.2.207

Ejemplares similares

Bevacizumab Plus Erlotinib Combination Therapy for Advanced Hereditary Leiomyomatosis and Renal Cell Carcinoma-Associated Renal Cell Carcinoma: A Multicenter Retrospective Analysis in Korean Patients
por: Choi, Yeonjoo, et al.
Publicado: (2019)

Long-term response of metastatic hereditary leiomyomatosis and renal cell carcinoma syndrome associated renal cell carcinoma to bevacizumab plus erlotinib after temsirolimus and axitinib treatment failures
por: Park, Inkeun, et al.
Publicado: (2019)

Hereditary leiomyomatosis and renal cell carcinoma
por: Schmidt, Laura S, et al.
Publicado: (2014)

Hereditary Leiomyomatosis and Renal Cell Cancer
por: HANSEN, Anders Würgler, et al.
Publicado: (2020)

Effectiveness of Adding Docetaxel to Androgen Deprivation Therapy for Metastatic Hormone-Sensitive Prostate Cancer in Korean Real-World Practice
por: Park, Kwonoh, et al.
Publicado: (2023)

A Case of Hereditary Leiomyomatosis and Renal Cell Carcinoma
por: Mehrtens, Sarah, et al.
Publicado: (2016)

A Non-Hereditary Case of Hereditary Leiomyomatosis and Renal Cell Carcinoma Syndrome
por: Kapila, Vaishali, et al.
Publicado: (2021)

Hereditary Leiomyomatosis and Renal Cell Cancer: A Case Report of Pilar Leiomyomatosis with History of Kidney Cancer and Review of the Literature
por: Kim, Jee-Woo, et al.
Publicado: (2023)

Hereditary leiomyomatosis and renal cell cancer: Cutaneous lesions & atypical fibroids
por: Bortoletto, Pietro, et al.
Publicado: (2017)

Hereditary leiomyomatosis and renal cell carcinoma: Case report and review of the literature
por: Natália, Ferreira, et al.
Publicado: (2018)

Nivolumab-Induced Encephalitis in Hereditary Leiomyomatosis and Renal Cell Cancer Syndrome
por: Chaucer, Benjamin, et al.
Publicado: (2018)

Hereditary leiomyomatosis and renal cell cancer (HLRCC): A case report
por: Yonamine, Tomoko, et al.
Publicado: (2020)

Unusual presentation of hereditary leiomyomatosis mimicking neurofibromatosis
por: Bevans, Stephanie L., et al.
Publicado: (2018)

Hereditary Leiomyomatosis and Renal Cell Cancer Syndrome in Spain: Clinical and Genetic Characterization
por: Sánchez-Heras, A. Beatriz, et al.
Publicado: (2020)

Hereditary leiomyomatosis and renal cell carcinoma: a case series and literature review
por: Chayed, Zahraa, et al.
Publicado: (2021)

Hereditary Leiomyomatosis and Renal Cell Cancer: Recent Insights Into Mechanisms and Systemic Treatment
por: Zhang, Congwang, et al.
Publicado: (2021)

Hereditary leiomyomatosis and renal cell cancer syndrome – case report and review of the literature
por: Popa, Liliana Gabriela, et al.
Publicado: (2020)

Hereditary Leiomyomatosis and Renal Cell Cancer-Recognizing Patterns May Save Lives
por: Catarina, Tavares, et al.
Publicado: (2022)

Hereditary Leiomyomatosis and Renal Cell Carcinoma: A Case Report and Review of the Literature
por: Alrawaf, Faisal A, et al.
Publicado: (2022)

Dermatologists might be the first to suspect hereditary leiomyomatosis and renal cell carcinoma syndrome()
por: González-Guerra, Elena, et al.
Publicado: (2023)

Efficacy and Safety of Everolimus in Korean Patients with Metastatic Renal Cell Carcinoma Following Treatment Failure with a Vascular Endothelial Growth Factor Receptor-Tyrosine Kinase Inhibitor
por: Park, Kwonoh, et al.
Publicado: (2014)

Proteogenomic landscape of uterine leiomyomas from hereditary leiomyomatosis and renal cell cancer patients
por: Bateman, Nicholas W., et al.
Publicado: (2021)

Post-transplant diagnosis of hereditary leiomyomatosis and renal cell carcinoma syndrome in a kidney donor
por: Lee, Jonathan J., et al.
Publicado: (2014)

Hereditary leiomyomatosis and renal cell carcinoma syndrome: a case report and implications of early onset
por: Çaliskan, Ercan, et al.
Publicado: (2017)

Fumarate hydratase inactivation in hereditary leiomyomatosis and renal cell cancer is synthetic lethal with ferroptosis induction
por: Kerins, Michael J., et al.
Publicado: (2018)

A novel case of hereditary leiomyomatosis- associated renal cell carcinoma with metastasis to pituitary gland
por: Palma, Catalina A., et al.
Publicado: (2022)

Birt-Hogg-Dubé Syndrome and Hereditary Leiomyomatosis and Renal Cell Carcinoma Syndrome: An Effective Multidisciplinary Approach to Hereditary Renal Cancer Predisposing Syndromes
por: Al-Shinnag, Mohammad, et al.
Publicado: (2021)

A sheep in wolf's clothing; a case of renal leiomyoma masquerading as hereditary leiomyomatosis and renal cell carcinoma
por: Uzzo, Nicole, et al.
Publicado: (2023)

A novel pathogenic variant of the FH gene in a family with hereditary leiomyomatosis and renal cell carcinoma
por: Yagi, Yasuto, et al.
Publicado: (2022)

Systemic treatment for advanced urothelial cancer: an update on recent clinical trials and current treatment options
por: Park, Inkeun, et al.
Publicado: (2020)

Hereditary leiomyomatosis and renal cell cancer presenting as metastatic kidney cancer at 18 years of age: implications for surveillance
por: van Spaendonck-Zwarts, Karin Y., et al.
Publicado: (2011)

2020 Korean guidelines for the management of metastatic prostate cancer
por: Kim, In-Ho, et al.
Publicado: (2021)

Complete Response of Hereditary Leiomyomatosis and Renal Cell Cancer (HLRCC)-Associated Renal Cell Carcinoma to Pembrolizumab Immunotherapy: A Case Report
por: Wang, Tao, et al.
Publicado: (2021)

Abnormal Cystic Tumor in a Patient with Hereditary Leiomyomatosis and Renal Cell Cancer Syndrome: Evidence of a Precursor Lesion?
por: Ristau, Benjamin T., et al.
Publicado: (2015)

Treatment of cutaneous leiomyomas with 5% lidocaine patches in a patient with hereditary leiomyomatosis and renal cell cancer (Reed syndrome)
por: Hsu, Tina, et al.
Publicado: (2017)

Novel Fumarate Hydratase Mutation in Siblings With Early Onset Uterine Leiomyomas and Hereditary Leiomyomatosis and Renal Cell Cancer Syndrome
por: Gunnala, Vinay, et al.
Publicado: (2018)

A few pink papules in an adult woman: Incidental finding leads to diagnosis of hereditary leiomyomatosis and renal cell cancer
por: Young, Kelly Z., et al.
Publicado: (2019)

Hereditary leiomyomatosis and renal cell cancer (HLRCC) syndrome in a young patient presenting with a large uterus: A case report and review of the literature
por: Shero, Nora, et al.
Publicado: (2023)

Metabolic Reprogramming for Producing Energy and Reducing Power in Fumarate Hydratase Null Cells from Hereditary Leiomyomatosis Renal Cell Carcinoma
por: Yang, Youfeng, et al.
Publicado: (2013)

Intravenous Leiomyomatosis
por: Mariyappa, Narayanaswamy, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_1vbsji3uvmr5v9hogrhu8621ur